title: Gabapentin in the treatment of hemifacial spasm.
abstract: OBJECTIVE
  To evaluate the efficacy of gabapentin in the treatment of hemifacial spasm.
  
  
  METHODS
  Twenty-three patients with hemifacial spasm not suitable for surgery or therapy with botulinum toxin were treated with gabapentin. The main efficacy parameter was the percentage of spasm reduction.
  
  
  RESULTS
  A clinically significant reduction of spasms was obtained by 16 patients.
  
  
  CONCLUSIONS
  Gabapentin was effective and safe in reducing hemifacial spasm in 16 out 23 (69.6%) patients.
authors.affiliation: Istituto di Neuropsichiatria - Università di Palermo, Italy. odaniele@neuro.unipa.it
authors.forename: O
authors.initials: O
authors.lastname: Daniele
authors.forename: G
authors.initials: G
authors.lastname: Caravaglios
authors.forename: C
authors.initials: C
authors.lastname: Marchini
authors.forename: L
authors.initials: L
authors.lastname: Mucchiut
authors.forename: P
authors.initials: P
authors.lastname: Capus
authors.forename: E
authors.initials: E
authors.lastname: Natalè
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D000077206:Gabapentin; D019569:Hemifacial Spasm / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin